Eli Lilly and Co (LLY)
745.13
+13.80
(+1.89%)
USD |
NYSE |
Apr 23, 16:00
745.69
+0.56
(+0.08%)
After-Hours: 16:16
Eli Lilly Cash and Short Term Investments (Quarterly): 2.928B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.928B |
| September 30, 2023 | 2.494B |
| June 30, 2023 | 2.829B |
| March 31, 2023 | 3.669B |
| December 31, 2022 | 2.212B |
| September 30, 2022 | 2.742B |
| June 30, 2022 | 2.737B |
| March 31, 2022 | 2.568B |
| December 31, 2021 | 3.909B |
| September 30, 2021 | 3.825B |
| June 30, 2021 | 3.271B |
| March 31, 2021 | 3.051B |
| December 31, 2020 | 3.681B |
| September 30, 2020 | 3.630B |
| June 30, 2020 | 2.388B |
| March 31, 2020 | 1.777B |
| December 31, 2019 | 2.438B |
| September 30, 2019 | 1.653B |
| June 30, 2019 | 2.368B |
| March 31, 2019 | 2.137B |
| December 31, 2018 | 7.409B |
| September 30, 2018 | 9.036B |
| June 30, 2018 | 6.910B |
| March 31, 2018 | 4.790B |
| December 31, 2017 | 8.034B |
| Date | Value |
|---|---|
| September 30, 2017 | 6.943B |
| June 30, 2017 | 5.434B |
| March 31, 2017 | 3.506B |
| December 31, 2016 | 6.039B |
| September 30, 2016 | 4.227B |
| June 30, 2016 | 3.935B |
| March 31, 2016 | 2.995B |
| December 31, 2015 | 4.452B |
| September 30, 2015 | 4.319B |
| June 30, 2015 | 4.231B |
| March 31, 2015 | 4.140B |
| December 31, 2014 | 4.827B |
| September 30, 2014 | 4.810B |
| June 30, 2014 | 5.126B |
| March 31, 2014 | 5.212B |
| December 31, 2013 | 5.397B |
| September 30, 2013 | 5.379B |
| June 30, 2013 | 4.711B |
| March 31, 2013 | 4.732B |
| December 31, 2012 | 5.684B |
| September 30, 2012 | 6.900B |
| June 30, 2012 | 5.262B |
| March 31, 2012 | 4.925B |
| December 31, 2011 | 6.897B |
| September 30, 2011 | 6.784B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.653B
Minimum
Sep 2019
3.909B
Maximum
Dec 2021
2.851B
Average
2.742B
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 10.94B |
| Biogen Inc | 1.050B |
| Madrigal Pharmaceuticals Inc | 634.13M |
| Vertex Pharmaceuticals Inc | 11.22B |
| Viking Therapeutics Inc | 362.08M |